Detrimental effects of microplastic exposure on normal and asthmatic pulmonary physiology

Kuo Lu1, Keng Po Lai2, Tobias Stoeger3

  • 1The Department of Respiratory Diseases and Critic Care Unit, Shenzhen Institute of Respiratory Disease, Shenzhen Key Laboratory of Respiratory Disease, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China; Post-Doctoral Scientific Research Station of Basic Medicine, Jinan University, Guangzhou 510632, China.

Insights

Airborne microplastics (MP) harm respiratory health in mice, causing inflammation and immune responses. Exposure negatively impacts both healthy lungs and asthma symptoms, highlighting risks of environmental pollutants.

Area of Science:

  • Environmental Health
  • Pulmonary Toxicology
  • Immunology

Background:

  • Growing concerns exist regarding the health impacts of airborne microplastics (MP).
  • Limited research has investigated the specific effects of MP on the respiratory system.
  • Understanding MP's effects on pulmonary physiology is crucial for public health.

Purpose of the Study:

  • To investigate the effects of microplastic exposure on normal and asthmatic pulmonary physiology in mice.
  • To elucidate the cellular and molecular mechanisms underlying MP-induced respiratory responses.

Main Methods:

  • Exposure of normal and asthmatic mice to microplastics.
  • Analysis of pulmonary inflammatory markers, including cell infiltration and cytokine levels (TNF-α).
  • Assessment of mucus production, immunoglobulin (IgG1) levels, and macrophage phagocytosis of MPs.
  • Comparative transcriptomic and bioinformatics analyses to identify affected gene clusters and molecular pathways.

Main Results:

  • Microplastic exposure led to pulmonary inflammation, macrophage aggregation, and increased TNF-α levels in normal mice.
  • In asthmatic mice, MP exposure exacerbated symptoms, increasing mucus production and inflammatory cell infiltration.
  • Evidence of macrophage phagocytosis of microplastics was observed.
  • Transcriptomic analysis revealed alterations in genes associated with immune response, cellular stress, and programmed cell death.
  • Bioinformatics identified a pathway involving TNF-α and immunoglobulins activating B-cell antigens, modulating stress and cell death in asthma.

Conclusions:

  • Microplastic exposure exerts detrimental effects on the respiratory system in both healthy and asthmatic individuals.
  • These findings underscore the urgent need to address environmental microplastic pollution and its potential health risks.
  • Further research is warranted to fully understand the long-term consequences of microplastic inhalation.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
846
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
692